Results 131 to 140 of about 2,763 (183)

Impact of Erenumab on Comorbid Depression, Anxiety, and Sleep Quality in Migraine: A Registry for Migraine (REFORM) Study. [PDF]

Eur J Neurol
Raffaelli B, Thuraiaiyah J, Christensen RH, Al-Khazali HM, Ashina H, Snellman J, Maio-Twofoot T, Ashina M.   +7 more
europepmc   +1 more source

CGRP and Migraine: Real-World Insights and Future Therapeutic Directions. [PDF]

Annu Rev Med
Russo AF, Kaiser EA.
europepmc   +1 more source

Sex-specific management of migraine a systematic review and consensus statement from the European Headache Federation (EHF). [PDF]

J Headache Pain
Braca S, Casillo F, Moreira S, Ekizoglu E, Bjork MH, Szewczyk AK, Van Dycke A, Uluduz D, Coppola G, Deligianni C, Lampl C, Tronvik E, Amin FM, Versijpt J, Ryliškienė K, Rio MSD, Holland PR, Terwindt G, Reuter U, MaassenVanDenBrink A, Gil-Gouveia R.   +20 more
europepmc   +1 more source

Permanent visual impairment following a Behçet's disease flare while on calcitonin gene-related peptide receptor antagonist therapy: a case report. [PDF]

BMC Ophthalmol
Khan FA, Malik A, Nelson E, Fahimdanesh K, Kaur K, Elison J, Sayed M.   +6 more
europepmc   +1 more source

Normal delivery following use of galcanezumab until the first and second trimesters of pregnancy: A report of 2 cases. [PDF]

Medicine (Baltimore)
Akiyama H, Yamano Y.
europepmc   +1 more source

Assessing the Occurrence of Hypertension in Patients Receiving Calcitonin Gene-Related Peptide Monoclonal Antibodies for Episodic and Chronic Migraine: A Systematic Review. [PDF]

Cureus
Kakde SP, Islam K, Ali MF, Anwar MS, Nadeem L, Rana AR, Rana AW, Hayat SK, Ali SM, Kolanu ND.   +9 more
europepmc   +1 more source

Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo-Controlled Study. [PDF]

Eur J Neurol
Tepper SJ, Dodick DW, Lanteri-Minet M, Dolezil D, Gil-Gouveia R, Lucas C, Piasecka-Stryczynska K, Szabó G, Mikol DD, Chehrenama M, Chou DE, Liu Z, da Silva Lima GP.   +12 more
europepmc   +1 more source

Decoding the long-term safety of anti-CGRP (receptor) mAbs: a meta-analysis and systematic review. [PDF]

J Headache Pain
Hoehne CL, Overeem LH, Sanchez-Del-Rio M, Deligianni C, Gil-Gouveia R, Versijpt J, Amin FM, Lampl C, Ryliskiene K, Tronvik E, Coppola G, Holland PR, MaassenVanDenBrink A, Martelletti P, Reuter U, European Headache Federation, EHF.   +16 more
europepmc   +1 more source

Long-term effectiveness of fremanezumab in episodic and chronic migraine patients in clinical routine - 24-months results from the prospective non-interventional FINESSE study. [PDF]

J Headache Pain
Straube A, Broessner G, Gaul C, Hamann X, Heinze A, Kraya T, Neeb L.   +6 more
europepmc   +1 more source

Persistence, switching, and healthcare use after initiating calcitonin gene-related peptide inhibitors: a real-world assessment. [PDF]

J Headache Pain
Moura CS, Randall JR, Klarenbach S, Behlouli H, Luu H, Amoozegar F, Kaboré JL, Bernatsky S.   +7 more
europepmc   +1 more source